1) Kolorektales Karzinom: Stellenwert Oxaliplatin-haltiger Therapieregime wächst. 2) Breites Aktivitätsspektrum von Oxaliplatin bei verschiedenen Tumoren. 3) Pharmakokinetik von Oxaliplatin in Risikogruppen

Publisher： Karger

E-ISSN： 2296-5262|24|4|1-8

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.4, 2001-09, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

1) Fortgeschrittenes kolorektales Karzinom. 2) Andere Tumorentitäten. 3) Kombination von Oxaliplatin mit anderen Substanzen. 4) Sicherheit. 5) Verschiedenes

By  

Oncology Research and Treatment, Vol. 24, Iss. 4, 2001-09 ,pp. : 9-41

Karger

Access to resources Recommend Favorite

Oxaliplatin beim Kolorektalkarzinom: Von der Palliation zur Kuration

By  

Oncology Research and Treatment, Vol. 27, Iss. 1, 2004-09 ,pp. : 2-11

Karger

Access to resources Recommend Favorite

Oxaliplatin-Related Ocular Toxicity

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-11 ,pp. : 423-427

Karger

Access to resources Recommend Favorite

Pharmacogenetics of Oxaliplatin as Adjuvant Treatment in Colon Carcinoma: Are Single Nucleotide Polymorphisms in GSTP1, ERCC1, and ERCC2 Good Predictive Markers?

By Sarasqueta Arantza Fariña   >  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 5, 2011-10 ,pp. : 277-283

Adis International

Access to resources Recommend Favorite

Kolorektales Karzinom – Primärtherapie bei fortgeschrittener Metastasierung

By  

Oncology Research and Treatment, Vol. 31, Iss. 5, 2008-11 ,pp. : 3-8

Karger

Access to resources Recommend Favorite